Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ries JD et al. - The TUG, the 6MWT, and gait speed are reliable outcome measures for use with people with AD, recognizing that individual variability of performance is high. Minimal detectable change scores at the 90% confidence interval can be used to assess change in performance over time and the impact of treatment.

Related Articles

High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09    Relevance Score: 70%

Dietary polypenols may delay onset of Alzheimer’s disease
Internet Source, 12/04/09    Relevance Score: 69%

New Cause for Alzheimer Disease
ScienceDaily, 11/30/09    Relevance Score: 69%

Activated astrocytes: a therapeutic target in Alzheimer's disease?
Expert Review of Neurotherapeutics, 11/19/09    Relevance Score: 69%

All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease
Expert Review of Neurotherapeutics, 11/19/09    Relevance Score: 68%

Today in Dementia...keeping you current

Subregional neuroanatomical change as a biomarker for Alzheimer's disease
Proceedings of the National Academy of Sciences of the United States of America, 12/10/09

Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer’s disease
Neurological Sciences, 12/10/09

Metabolic Syndrome and the Risk of Vascular Dementia. The Italian Longitudinal Study on Aging
Journal of Neurology, Neurosurgery, and Psychiatry , 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address